BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23908141)

  • 21. Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer.
    Suzuki H; Li Y; Dong X; Hassan MM; Abbruzzese JL; Li D
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3467-73. PubMed ID: 19064563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A regulatory variant in CYP2E1 affects the risk of lung squamous cell carcinoma.
    Cao L; Lin J; He B; Wang H; Rao J; Liu Y; Zhang X
    Tumour Biol; 2014 Jan; 35(1):455-62. PubMed ID: 23934444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic polymorphisms of MDM2, cumulative cigarette smoking and nonsmall cell lung cancer risk.
    Liu G; Wheatley-Price P; Zhou W; Park S; Heist RS; Asomaning K; Wain JC; Lynch TJ; Su L; Christiani DC
    Int J Cancer; 2008 Feb; 122(4):915-8. PubMed ID: 17957785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China.
    Song N; Tan W; Xing D; Lin D
    Carcinogenesis; 2001 Jan; 22(1):11-6. PubMed ID: 11159735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. XRCC1 polymorphism and lung cancer risk in relation to tobacco smoking.
    Schneider J; Classen V; Bernges U; Philipp M
    Int J Mol Med; 2005 Oct; 16(4):709-16. PubMed ID: 16142409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactive effect of cigarette smoking with human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) polymorphisms on the risk of lung cancer: a case-control study in Taiwan.
    Chang CH; Hsiao CF; Chang GC; Tsai YH; Chen YM; Huang MS; Su WC; Hsieh WS; Yang PC; Chen CJ; Hsiung CA
    Am J Epidemiol; 2009 Sep; 170(6):695-702. PubMed ID: 19671832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial DNA copy number and pancreatic cancer in the alpha-tocopherol beta-carotene cancer prevention study.
    Lynch SM; Weinstein SJ; Virtamo J; Lan Q; Liu CS; Cheng WL; Rothman N; Albanes D; Stolzenberg-Solomon RZ
    Cancer Prev Res (Phila); 2011 Nov; 4(11):1912-9. PubMed ID: 21859925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Body mass index and obesity- and diabetes-associated genotypes and risk for pancreatic cancer.
    Tang H; Dong X; Hassan M; Abbruzzese JL; Li D
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):779-92. PubMed ID: 21357378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control study.
    Hassan MM; Abbruzzese JL; Bondy ML; Wolff RA; Vauthey JN; Pisters PW; Evans DB; Khan R; Lenzi R; Jiao L; Li D
    Cancer; 2007 Jun; 109(12):2547-56. PubMed ID: 17492688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in different histological subtypes of lung cancer.
    Zhou W; Thurston SW; Liu G; Xu LL; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):461-6. PubMed ID: 11352855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antioxidant genes, diabetes and dietary antioxidants in association with risk of pancreatic cancer.
    Tang H; Dong X; Day RS; Hassan MM; Li D
    Carcinogenesis; 2010 Apr; 31(4):607-13. PubMed ID: 20097730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active cigarette smoking, variants in carcinogen metabolism genes and breast cancer risk among pre- and postmenopausal women in Ontario, Canada.
    Cotterchio M; Mirea L; Ozcelik H; Kreiger N
    Breast J; 2014; 20(5):468-80. PubMed ID: 25052559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lifestyle, dietary, and medical history factors associated with pancreatic cancer risk in Ontario, Canada.
    Anderson LN; Cotterchio M; Gallinger S
    Cancer Causes Control; 2009 Aug; 20(6):825-34. PubMed ID: 19194662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk.
    Zhou W; Liu G; Miller DP; Thurston SW; Xu LL; Wain JC; Lynch TJ; Su L; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):359-65. PubMed ID: 12692111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CYP1A1 polymorphisms and risk of lung cancer in the ethnic Kashmiri population.
    Shaffi SM; Shah MA; Bhat IA; Koul P; Ahmad SN; Siddiqi MA
    Asian Pac J Cancer Prev; 2009; 10(4):651-6. PubMed ID: 19827888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of the cytochrome P4501A2, SULT1A1 and NAT gene polymorphisms with smoking and dietary mutagen intake in modification of the risk of pancreatic cancer.
    Suzuki H; Morris JS; Li Y; Doll MA; Hein DW; Liu J; Jiao L; Hassan MM; Day RS; Bondy ML; Abbruzzese JL; Li D
    Carcinogenesis; 2008 Jun; 29(6):1184-91. PubMed ID: 18499698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II Drug-Metabolizing Polymorphisms and Smoking Predict Recurrence of Non-Muscle-Invasive Bladder Cancer: A Gene-Smoking Interaction.
    Lacombe L; Fradet V; Lévesque É; Pouliot F; Larue H; Bergeron A; Hovington H; Caron A; Nguile-Makao M; Harvey M; Fradet Y; Guillemette C
    Cancer Prev Res (Phila); 2016 Feb; 9(2):189-95. PubMed ID: 26645279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian population.
    Boccia S; Sayed-Tabatabaei FA; Persiani R; Gianfagna F; Rausei S; Arzani D; La Greca A; D'Ugo D; La Torre G; van Duijn CM; Ricciardi G
    BMC Cancer; 2007 Nov; 7():206. PubMed ID: 17996038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Copy number variations of GSTT1 and GSTM1, colorectal cancer risk and possible effect modification of cigarette smoking and menopausal hormone therapy.
    Rudolph A; Hein R; Hoffmeister M; Försti A; Hemminki K; Risch A; Brenner H; Chang-Claude J
    Int J Cancer; 2012 Sep; 131(5):E841-8. PubMed ID: 22234881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-acetyltransferase 2 gene polymorphism as a biomarker for susceptibility to bladder cancer in Bangladeshi population.
    Hosen MB; Islam J; Salam MA; Islam MF; Hawlader MZ; Kabir Y
    Asia Pac J Clin Oncol; 2015 Mar; 11(1):78-84. PubMed ID: 25376209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.